Skip to content Norwegian Medical Products Agency Norwegian Medical Products Agency

NOMA at GIDWG meeting in Brasil discussing PhPID for grouping medicinal products

Published:

|

Updated:

Changes

Earlier in September, the Norwegian Medical Products Agency (NOMA) and South-Eastern Norway Regional Health Authority (Helse Sørøst) participated in a meeting in São Paulo, organised by the Global IDMP Working Group (GIDWG).

They presented the SAFEST project, which focuses on using ISO IDMP Pharmaceutical Product Identifiers (PhPID) for grouping medicinal products for substance prescribing in Norwegian hospitals.

The GIDWG aims to globally implement ISO IDMP throughout all phases of the medicinal product lifecycle, ensuring data consistency among national and international actors. With standardised medicinal product data adhering to ISO IDMP, regulatory processes will become more efficient, collaboration between stakeholders will improve, and international trade of medicinal products will be simplified.

The meeting's theme was the use of ISO IDMP PhPID for grouping medicinal products. PhPID will be used globally to manage medicine shortages, detect, and alert adverse drug reactions, and facilitate cross-border electronic prescriptions and updates to the EU’s EHDS (European Health Data Space) patient’s medicinal product lists. The Uppsala Monitoring Centre (WHO-UMC) has been tasked with creating a global system for PhPID generation. This system, comprising an operational model, global harmonisation rules, and a technical platform, is currently under testing and NOMA has contributed to this.

Increased Confidence in SAFEST Project Decisions

"It was both pleasant and inspiring to meet with colleagues from various continents, all working towards the same goal: standardising medicinal product master data using ISO IDMP and employing PhPID for medicine grouping. Working alongside leading and strategic healthcare organisations worldwide is motivating and strengthens our belief that we are making the right decisions in the SAFEST project," says Kristine Aasen. Aasen, an enterprise architect at NOMA, was invited to the GIDWG meeting alongside Elin May Merry and Bernd Moeske, who represent Helse Sørøst in the SAFEST project. Together, they gave a well-received presentation that garnered significant attention at the GIDWG meeting.

Left: Malin Fladvad from the Uppsala Monitoring Centre (WHO-UMC) with Bernd Moeske and Elin May Merry from Health South-East. Right: Kristine Aasen from NOMA.

Left: Malin Fladvad from the Uppsala Monitoring Centre (WHO-UMC) with Bernd Moeske and Elin May Merry from Helse Sørøst.
Right: Kristine Aasen from NOMA.

See more news

Contact us

Norwegian Medical Products Agency

(+47) 22 89 77 00

post@noma.no